140 related articles for article (PubMed ID: 8246267)
21. Serum IgG response to Burkholderia cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with Pseudomonas aeruginosa.
Lacy DE; Smith AW; Stableforth DE; Smith G; Weller PH; Brown MR
FEMS Immunol Med Microbiol; 1995 Feb; 10(3-4):253-61. PubMed ID: 7539670
[TBL] [Abstract][Full Text] [Related]
22. The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion.
Hornick DB; Fick RB
J Clin Invest; 1990 Oct; 86(4):1285-92. PubMed ID: 2120286
[TBL] [Abstract][Full Text] [Related]
23. Association with phagocytic inhibition of anti-Pseudomonas aeruginosa immunoglobulin G antibody subclass levels in serum from patients with cystic fibrosis.
Shryock TR; Mollé JS; Klinger JD; Thomassen MJ
J Clin Microbiol; 1986 Mar; 23(3):513-6. PubMed ID: 3082922
[TBL] [Abstract][Full Text] [Related]
24. Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: correlations with pulmonary function, neutrophil chemotaxis, and phagocytosis.
Cowan RG; Winnie GB
J Clin Immunol; 1993 Sep; 13(5):359-70. PubMed ID: 8245182
[TBL] [Abstract][Full Text] [Related]
25. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
26. The influence of allotypes on the IgG subclass response to chromosomal beta-lactamase of Pseudomonas aeruginosa in cystic fibrosis patients.
Ciofu O; Pressler T; Pandey JP; Høiby N
Clin Exp Immunol; 1997 Apr; 108(1):88-94. PubMed ID: 9097916
[TBL] [Abstract][Full Text] [Related]
27. Increased levels of IgG subclasses specific for Pseudomonas aeruginosa exoenzyme and polysaccharide antigens in chronically infected patients with cystic fibrosis.
Albus A; Saalmann M; Tesch H; Pedersen SS; Döring G
APMIS; 1989 Dec; 97(12):1146-8. PubMed ID: 2482060
[TBL] [Abstract][Full Text] [Related]
28. Influence of Gm allotype on the IgG subclass response to streptococcal M protein and outer membrane proteins of Moraxella catarrhalis.
Carson RT; McDonald DF; Kehoe MA; Calvert JE
Immunology; 1994 Sep; 83(1):107-13. PubMed ID: 7529743
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal serum IgG response to Pseudomonas cepacia surface antigens in cystic fibrosis.
Aronoff SC; Quinn FJ; Stern RC
Pediatr Pulmonol; 1991; 11(4):289-93. PubMed ID: 1722035
[TBL] [Abstract][Full Text] [Related]
30. Conformation-dependent antibody response to Pseudomonas aeruginosa outer membrane proteins induced by immunization in humans.
Lee N; Ahn B; Jung SB; Kim YG; Kim H; Park WJ
FEMS Immunol Med Microbiol; 2000 Jan; 27(1):79-85. PubMed ID: 10617794
[TBL] [Abstract][Full Text] [Related]
31. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis.
Nelson JW; Butler SL; Brown PH; Greening AP; Govan JR
J Med Microbiol; 1993 Jul; 39(1):39-47. PubMed ID: 7686977
[TBL] [Abstract][Full Text] [Related]
32. Antibody responses to Porphyromonas gingivalis hemagglutinin A and outer membrane protein in chronic periodontitis.
Kobayashi T; Kaneko S; Tahara T; Hayakawa M; Abiko Y; Yoshie H
J Periodontol; 2006 Mar; 77(3):364-9. PubMed ID: 16512750
[TBL] [Abstract][Full Text] [Related]
33. Functional importance of cystic fibrosis immunoglobulin G fragments generated by Pseudomonas aeruginosa elastase.
Bainbridge T; Fick RB
J Lab Clin Med; 1989 Dec; 114(6):728-33. PubMed ID: 2512365
[TBL] [Abstract][Full Text] [Related]
34. Strategies of Pseudomonas aeruginosa to colonize and to persist in the cystic fibrosis lung.
Kubesch P; Lingner M; Grothues D; Wehsling M; Tümmler B
Scand J Gastroenterol Suppl; 1988; 143():77-80. PubMed ID: 3133755
[TBL] [Abstract][Full Text] [Related]
35. Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.
Fick RB; Naegel GP; Squier SU; Wood RE; Gee JB; Reynolds HY
J Clin Invest; 1984 Jul; 74(1):236-48. PubMed ID: 6429195
[TBL] [Abstract][Full Text] [Related]
36. Serum IgA and IgG subclasses during treatment for acute respiratory exacerbation in cystic fibrosis: analysis of patients colonised with mucoid or non-mucoid strains of pseudomonas aeruginosa.
Hassan J; Feighery C; Bresnihan B; Keogan M; Fitzgerald MX; Whelan A
Immunol Invest; 1994 Jan; 23(1):1-13. PubMed ID: 8144195
[TBL] [Abstract][Full Text] [Related]
37. Characterization of antibody-mediated inhibition of Pseudomonas aeruginosa adhesion to epithelial cells.
Sexton M; Reen DJ
Infect Immun; 1992 Aug; 60(8):3332-8. PubMed ID: 1639501
[TBL] [Abstract][Full Text] [Related]
38. Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G; Shand GH; Fomsgaard A; Høiby N
APMIS; 1992 Feb; 100(2):175-80. PubMed ID: 1554493
[TBL] [Abstract][Full Text] [Related]
39. IgG subclasses and chronic bacterial infection. Subclass antibodies and the clinical course of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
Pressler T
APMIS Suppl; 1996; 66():1-41. PubMed ID: 8972694
[No Abstract] [Full Text] [Related]
40. Anti-LPS IgA and IgG Can Inhibit Serum Killing of Pseudomonas aeruginosa in Patients with Cystic Fibrosis.
Pham A; Ledger EL; Coggon CF; Henderson IR; Reid DW; Bell SC; Smith DJ; Wells TJ
Infect Immun; 2021 Nov; 89(12):e0041221. PubMed ID: 34460286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
